Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform

News   Mar 26, 2012

 
Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform
 
 
 

RELATED ARTICLES

New Partnership to Provide Bioanalytical and DMPK Services

News

Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

Toothpaste Ingredient Could Help Fight Drug-Resistant Malaria

News

An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.

READ MORE

Radical New Approach to Vaccine Development Could Help Reduce Illness From Flu

News

More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help lower that figure for future flu seasons.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE